| Filed On | Filing |
|---|---|
| 16 Jul 2026 |
8-K/A: Financial Statements and Exhibits
On May 31, 2026, Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) entered into a definitive Asset Purchase Agreement (the “APA”) with Servier Pharmaceuticals LLC and Les Laboratoires Servier (together, “Servier” or the “Buyers”)... |
Loading...
